Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China's Big Cities Should Be First Priority For Pharma Companies - IMS

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI- China's largest cities control the majority of the Chinese pharma market, and companies must decide city-specific sales strategies, according to the global healthcare data provider and consulting firm IMS Health

You may also be interested in...



Expansion Into China's Lower-Tier Cities Could Be Growth Driver For Big Pharma

China's smaller cities are emerging rapidly as growth areas, while Big Pharma is still focused mostly on Tier 1 cities such as Shanghai, Beijing and Guangzhou, according to IMS Health.

Expansion Into China's Lower-Tier Cities Could Be Growth Driver For Big Pharma

China's smaller cities are emerging rapidly as growth areas, while Big Pharma is still focused mostly on Tier 1 cities such as Shanghai, Beijing and Guangzhou, according to IMS Health.

Expansion Into China's Lower-tier Cities Could Be Growth Driver For Big Pharma

SHANGHAI - China's pharma market is expected to continue to grow in the next five years with a CAGR of 23.2%, which will be backed largely by the expansion of community health centers across tier 2 and tier 3 cities, according to a report issued by consultancy IMS Health

Related Content

UsernamePublicRestriction

Register

AG032815

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel